Latest News and Press Releases
Want to stay updated on the latest news?
-
Enrollment in the Pivotal Phase 3 OVATION 3 Study Advances Company Toward Future BLA Filing New Data from MRD Study Reinforces IMNN-001's Promise as a Potential Breakthrough Immunotherapy ...
-
2024 Highlights Include Proposed Strategic Business Combination and Progress at Flagship Peak Project